Complete financial analysis of Synovics Pharmaceuticals, Inc. (SYVC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Synovics Pharmaceuticals, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- EPR Properties (EPR-PG) Income Statement Analysis – Financial Results
- VPower Group International Holdings Limited (1608.HK) Income Statement Analysis – Financial Results
- Clientèle Limited (CLI.JO) Income Statement Analysis – Financial Results
- Sybly Industries Limited (SYBLY.BO) Income Statement Analysis – Financial Results
- Ölgerðin Egill Skallagrímsson hf. (OLGERD.IC) Income Statement Analysis – Financial Results
Synovics Pharmaceuticals, Inc. (SYVC)
Industry: Biotechnology
Sector: Healthcare
About Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company's OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.
Source: https://incomestatements.info
Category: Stock Reports